Business transformation services - cost allocation for centrally administered services

Ended Awarded Last action

Contract number
HHSF22315002
Awardee
Awarding agency
Obligated
$11,849,027

Award facts

Opportunity
  • TFTPMC000874B Solicitation number
Contract value 100% obligated
$11,849,026.99 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
Pricing
Labor Hours
Place of performance
Silver Spring, MD 20993, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out P00013 -$670,412
Other Administrative Action P00012 $0
Exercise an Option P00011 · Cost allocation extension $800,000
Additional Work (new agreement, FAR part 6 applies) P00010 $2,694,213
Exercise an Option 9 $2,550,725
Other Administrative Action 8 $0
Exercise an Option 7 $2,253,388
Other Administrative Action 6 $0
Supplemental Agreement for work within scope 5 $509,975
Other Administrative Action 4 · Cost allocation $0
Exercise an Option 3 $1,890,703
Supplemental Agreement for work within scope 2 · Business transformation services $0
Supplemental Agreement for work within scope 1 · Business transformation $253,175
Original award $1,567,261
Show all 14

About this award

This is a federal contract award from the Food and Drug Administration (FDA) to Deloitte Consulting LLP, doing business as Deloitte. The contract is for $11,849,026.99 and is for business transformation services - specifically, cost allocation for centrally administered services. The contract is a call against the Mission Oriented Business Integrated Services (MOBIS) Multiple Award Schedule contract vehicle. It is not a set-aside contract. The contract provides for the delivery of IT modernization, data analytics, cybersecurity, program management, and organizational transformation services to the FDA. Deloitte is a leading global management and technology consulting firm that supports numerous civilian and defense agencies through prime contracts, subcontracts, and strategic partnerships. The company has secured significant Indefinite Delivery Vehicles (IDVs) with the Department of Veterans Affairs, Army, Internal Revenue Service, and National Institutes of Health, among others, which enable Deloitte to provide comprehensive services across the federal government.

Quick answers

Who was awarded contract HHSF22315002?

HHSF22315002 was awarded to Deloitte Consulting LLP by Food and Drug Administration (Department of Health and Human Services) on September 11, 2015.

How much is contract HHSF22315002 worth?

The government has obligated $11,849,027 on HHSF22315002.

Is contract HHSF22315002 an order under another contract?

Yes. HHSF22315002 is a BPA call under GS10F0083L-HHSF223201510010B, a blanket purchase agreement, on Mission Oriented Business Integrated Services (MOBIS).

Was contract HHSF22315002 competed?

The extent of competition for HHSF22315002 was full and open competition. The government received 2 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award